Johnson Matthey

London, Great Britainwww.matthey.com/
Invested through
  • Triodos Pioneer Impact Fund
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
Bloomberg tickerJMAT LN
ISIN codeGB00BZ4BQC70
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Johnson Matthey is a specialty chemicals company. It operates through four segments: In Clean Air (63% of sales in FY20) it sells catalyst and catalyst systems to reduce emissions from the automotive and energy markets, within Efficient Natural Resources (23%) it develops products and processes that transform, conserve and recycle scarce resources across the chemicals, energy, automotive and pharmaceutical markets, Health (5%) where the company manufactures active pharmaceutical ingredients for niche areas in the pharmaceutical market, and New Markets (9%) where it develops products for emerging opportunities such as fuel cells addressing shifts taking place in the automotive, chemicals and energy markets.

Founded in 1817, the company has over 15,000 employees and operates in over 30 countries.

Investment rationale

Clean air: Johnson Matthey is a global leader in the development and production of emission control catalysts. Approximately a third of cars worldwide use its catalysts, thus preventing 20 million tonnes of pollutants per year from reaching the atmosphere.
Use of natural resources: the company is the world's biggest recycler of platinum group metals and it aims to increase the percentage of products sold with an end-of-life solution.
Healthcare: the company manufactures the vital compounds known as active pharmaceutical ingredients (APIs) and other specialist products used in drug development that pharmaceutical companies need to create life changing medicines.

Johnson Matthey targets to minimise its environmental footprint, reduce water consumption and waste and achieve net zero by 2040. The company also has targets related to its people to improve safety and diversity.